1Armani A, Becher RC. The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: Part I. Am Heart J ,2005,149: 971-976. 被引量：1
2Devaraj S, Venugopal S, Jialal I. Native pentameric C-reactive protein displays more potent pro-atherogenie activities in human aortic endothelial cells than modified C-reactive protein. Atherosclerosis, 2005,184: 48-52. 被引量：1
3Devaraj S,Du Clos TW ,Jialal I. Binding and internalization of C-reactive protein by Fcgamma receptors on human aortic endothelial cells mediates biological effects. Arterioscler Thromb Vasc Biol, 2005,26 : 1359-1363. 被引量：1
4Qamirani E, Ren Y, Kuo L, et al. C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD (P) H oxidase. Arterioscler Thromb Vasc Biol, 2005,25:995-1001. 被引量：1
5Kibayashi E, Urakazal M,Kobashi C, et al. Inhibitory effect of pitavastatin (NK-104) on the C-reactive protein-induced interleukin-8 production in human aortic endothelial cell. Clin Sci (Lond) ,2005,108:515-521. 被引量：1
6Verma S, Badiwala MV, Weisel RD, et al. C-reactive protein upregulates the NF-κB signaling pathway in saphenous vein endothelial cells:implications for atherosclerosis and restenosis. J Thorac Cardiovasc Surg, 2003,126:1886-1891. 被引量：1
7Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation ,2002,106:913-919. 被引量：1
8Venugopal SK, Devaraj S, Jialal I, et al. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation, 2003,108 : 1676-1678. 被引量：1
9Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation ,2002,105 : 1890-1896. 被引量：1
10Wang CH,Li SH ,Weisel RD, et al. C-reactive protein upgratulates angiotensin type I receptors in vascular smooth muscle. Circulation ,2003, 107 : 1783-1790. 被引量：1
